QuickView for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=BFD709773B2C37E861D32D9AA978BE47;jsessionid=8D18D6655260454546BEE31ADA6F5788;jsessionid=75D9786AF09A7209ADE2CB4A7B3C5A7D (gene)

1. An electrophilic fragment screening for the development of small molecules targeting caspase-2.
2. Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis.
3. Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias.
4. Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Model…
5. Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.

There were no clinical trials for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=BFD709773B2C37E861D32D9AA978BE47;jsessionid=8D18D6655260454546BEE31ADA6F5788;jsessionid=75D9786AF09A7209ADE2CB4A7B3C5A7D